Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
137.75
2.81 (2.08%)
At close: Aug 15, 2025, 2:39 PM

Biogen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.53B 1.48B 1.63B 1.61B 1.16B 1.17B 1.16B 1.46B 2.67B 3.13B 2.96B 2.39B 1.57B 1.54B 1.73B 2.11B 2.49B 3.07B
Depreciation & Amortization
744.3M 708.9M 673.2M 629.3M 571.5M 530M 494.8M 474.5M 470.2M 487.6M 518.4M 533.3M 545.8M 483.9M 487.7M 443.4M 425M 465M
Stock-Based Compensation
303.7M 299.4M 291.2M 271M 260.5M 263.6M 266.4M 278.7M 280.1M 262.1M 254.1M 245.7M 237.8M 236.2M 238.6M 228.8M 210.8M 200.7M
Other Working Capital
150.7M -125.1M -75.6M -274.5M -461.3M -576.5M -630.3M -1.36B -1.19B -126.1M -387.3M 351.5M 281.4M -589.2M -54.9M -4.9M -644.9M -462.2M
Other Non-Cash Items
-553.8M 579.8M 592.2M 471.8M 727.3M 581.1M 581.2M 541.2M -387.9M -1.67B -1.29B -1.13B -24.5M 1.78B 1.76B 826.4M 398.8M -113.1M
Deferred Income Tax
-170.1M -225.8M -158.1M -27.8M -182M -201.4M -305.8M -406.5M -292M -234.1M -168.6M 183.5M 148.5M -410.8M -426.8M -813M -654M 97.1M
Change in Working Capital
262.1M -260M -155.2M -831.6M -751M -693.3M -648.7M -988.1M -1.31B -293.9M -890.3M 173.4M 59.6M -594.8M -145.5M -356.8M -57.6M -190.5M
Operating Cash Flow
2.12B 2.58B 2.88B 2.13B 1.78B 1.65B 1.55B 1.36B 1.43B 1.68B 1.38B 2.4B 2.54B 3.03B 3.64B 2.43B 2.81B 3.53B
Capital Expenditures
-260M -286M -359.8M -358.7M -316.3M -360.7M -306.4M -328.6M -300.1M -251.9M -243.2M -224.3M -227.1M -260.2M -294.9M -327.4M -349.6M -382.7M
Cash Acquisitions
-1.07B -1.07B -1.07B -1.67B -6.93B -6.15B -6.15B -6.55B 376.8M 595M 594.8M 1.56B 942.3M -48M -19.9M 573.7M 169.9M 28.1M
Purchase of Investments
n/a n/a n/a n/a -1.02B -3.82B -5.14B -5.78B -5.26B -3.64B -3.45B -4.24B -4.49B -4.03B -3.81B -4.56B -4.71B -6.07B
Sales Maturities Of Investments
87.2M 89.1M 144.7M 110.1M 5.77B 7.12B 7.5B 8.05B 3.99B 3.57B 3.67B 4.48B 3.42B 3.13B 3.5B 4.25B 5.04B 5.89B
Other Investing Acitivies
-178.4M 350.1M 284.6M 301.9M 412.2M -70.3M 4.5M 1.03B 1.02B 1B 1B 30M 60.9M 58M 60.9M -553.9M -582.6M -589.2M
Investing Cash Flow
-1.3B -780.5M -799.2M -1.43B -1.99B -3.21B -4.1B -3.59B -175.4M 1.27B 1.58B 1.6B -300.8M -1.15B -563.7M -617.4M -436.2M -1.12B
Debt Repayment
n/a -250M -650M -1.3B -462.7M -212.7M 187.3M 837.3M -1B -1B -1B -1B n/a -700K -170M -169.9M -169.9M 1.3B
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a 750M 500M n/a n/a 1.05B 550M 600M n/a -2.2B -2.7B -5.06B
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-33.4M -16.9M -33.5M -41.2M -32.4M -47M 9.3M 1.7M -200K 38.1M 25.7M 42.9M 46.1M -96.2M -116.2M -127.2M -193.6M -51.6M
Financial Cash Flow
-33.4M -266.9M -683.5M -1.34B -482.3M -246.9M 149.3M 788M -1.31B -1.77B -1.75B -1.73B -1.22B -1.32B -2.09B -2.5B -3.06B -3.81B
Net Cash Flow
849.9M 1.52B 1.33B -588.7M -708.9M -1.82B -2.37B -1.39B -28.8M 1.15B 1.16B 2.13B 904.6M 531.8M 930.2M -683M -642.9M -1.37B
Free Cash Flow
1.86B 2.3B 2.52B 1.77B 1.47B 1.28B 1.24B 1.03B 1.13B 1.43B 1.14B 2.17B 2.31B 2.77B 3.35B 2.11B 2.46B 3.15B